5 Results for "

HA966

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "HA966" in MCE Product Catalog:

Cat. No.: HY-100822
CAS No.: 123931-04-4
Purity:  98.85%
Synonyms: (+)-HA-966
Target:  

iGluR

Research Areas:  

Neurological Disease

(R)-(+)-HA-966 ((+)-HA-966) is a partial agonist/antagonist of glycine site of the N-methyl-D-aspartate (NMDA) receptor complex. (R)-(+)-HA-966 selectively blocks the activation of the mesolimbic dopamine system by amphetamine . (R)-(+)-HA-966 can cross the blood-brain barrier and has the potential for neuropathic and acute pain .
loading...
    loading...
Cat. No.: HY-W424730
CAS No.: 42585-88-6
Target:  

iGluR

Research Areas:  

Others

HA-966 hydrochloride is a glycine site antagonist of the NMDA receptor, exhibiting non-competitive antagonism on NMDA responses. HA-966 hydrochloride effectively blocks the enhancement of NMDA responses by glycine in a competitive manner. HA-966 hydrochloride plays a significant role in mediating the antagonist action at the glycine modulatory site of the NMDA receptor.
loading...
    loading...
Cat. No.: HY-100822R
CAS No.: 123931-04-4
Synonyms: (+)-HA-966 (Standard)
Research Areas:  

Neurological Disease

(R)-(+)-HA-966 (Standard) is the analytical standard of (R)-(+)-HA-966 (HY-100822). This product is intended for research and analytical applications. (R)-(+)-HA-966 ((+)-HA-966) is a partial agonist/antagonist of glycine site of the N-methyl-D-aspartate (NMDA) receptor complex. (R)-(+)-HA-966 selectively blocks the activation of the mesolimbic dopamine system by amphetamine . (R)-(+)-HA-966 can cross the blood-brain barrier and has the potential for neuropathic and acute pain .
loading...
    loading...
Cat. No.: HY-100822A
CAS No.: 111821-58-0
Synonyms: (-)-HA 966
Target:  

iGluR

Research Areas:  

Neurological Disease

(S)-(-)-HA 966 ((-)-HA 966), a γ-Hydroxybutyrate-like agent, is weakly active as an NMDA-receptor antagonist. (S)-(-)-HA 966 possesses muscle relaxant action and prevents enhanced mesocorticolimbic dopamine metabolism and behavioral correlates of restraint stress, conditioned fear .
loading...
    loading...
Cat. No.: HY-118275
CAS No.: 133920-70-4
Target:  

Cholinesterase (ChE)

Research Areas:  

Neurological Disease

FK960 is a potential anti-dementia agent that reverses the reduction in cerebral blood flow (rCBF) caused by sensory stimulation by enhancing cholinergic neurotransmission. In macaque experiments, physostigmine (AChE inhibitor; HY-N6608) was able to completely eliminate the rCBF in the sensory cortex increased by vibrotactile stimulation. FK960 (1-1000 μg/kg) can restore the eliminated rCBF response, and the action time can last for 1 hour. However, FK960 cannot restore the rCBF response eliminated by HA-966 (NMDA modulator; HY-100822), indicating that its function is not dependent on non-glutamatergic neurotransmission.
loading...
    loading...